Skip to main content

Advertisement

SpringerLink
Log in

Extensive and severe CNS demyelination associated with golimumab therapy

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Nanau RM, Neuman MG (2014) Safety of anti-tumor necrosis factor therapies in arthritis patients. J Pharm Pharm Sci 17(3):324–361

    Article  CAS  PubMed  Google Scholar 

  2. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302. doi:10.1002/ana.22366

    Article  PubMed  PubMed Central  Google Scholar 

  3. Tristano AG (2010) Neurological adverse events associated with anti-tumor necrosis factor alpha treatment. J Neurol 257(9):1421–1431. doi:10.1007/s00415-010-5591-7

    Article  PubMed  Google Scholar 

  4. Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, Richert JR, Siegel JN (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44(12):2862–2869

    Article  CAS  PubMed  Google Scholar 

  5. Cruz Fernandez-Espartero M, Perez-Zafrilla B, Naranjo A, Esteban C, Ortiz AM, Gomez-Reino JJ, Carmona L, BIOBADASER Study Group (2011) Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review. Semin Arthritis Rheum 41(3):524–533. doi:10.1016/j.semarthrit.2011.05.003

    Article  CAS  PubMed  Google Scholar 

  6. Ramos-Casals M, Roberto Perez A, Diaz-Lagares C, Cuadrado MJ, Khamashta MA, BIOBADASER Study Group (2010) Autoimmune diseases induced by biological agents: a double-edged sword? Autoimmun Rev 9(3):188–193. doi:10.1016/j.autrev.2009.10.003

    Article  CAS  PubMed  Google Scholar 

  7. Kay J, Fleischmann R, Keystone E, Hsia EC, Hsu B, Mack M, Goldstein N, Braun J, Kavanaugh A (2015) Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. Ann Rheum Dis 74(3):538–546. doi:10.1136/annrheumdis-2013-204195

    Article  CAS  PubMed  Google Scholar 

  8. Matsumoto T, Nakamura I, Miura A, Momoyama G, Ito K (2013) New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review. Clin Rheumatol 32(2):271–275. doi:10.1007/s10067-012-2113-2

    Article  PubMed  Google Scholar 

  9. Seror R, Richez C, Sordet C, Rist S, Gossec L, Direz G, Houvenagel E, Berthelot JM, Pagnoux C, Dernis E, Melac-Ducamp S, Bouvard B, Asquier C, Martin A, Puechal X, Mariette X, Club Rhumatismes et Inflammation Section of the SFR (2013) Pattern of demyelination occurring during anti-TNF-alpha therapy: a French national survey. Rheumatology 52(5):868–874. doi:10.1093/rheumatology/kes375

    Article  CAS  PubMed  Google Scholar 

  10. Cereda CW, Zecca C, Mazzucchelli L, Valci L, Staedler C, Bassetti CL, Gobbi C (2013) Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy. Mult Scler 19(6):820–823. doi:10.1177/1352458512461969

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology Department, Pitié-Salpêtrière Hospital, APHP, 47-83 Boulevard de l’hôpital, 75013, Paris, France

    Elisabeth Maillart, Caroline Papeix, Catherine Lubetzki & Céline Louapre

  2. Neuroradiology Department, Sainte-Anne Hospital, Centre de Psychiatrie et Neurosciences, INSERM U894, Paris, France

    Charles Mellerio

  3. Neuroradiology Department, XV-XX Hospital, Paris, France

    Charles Mellerio

  4. Diagnostic and Functional Neuroradiology Department, Pitié-Salpêtrière Hospital, APHP, Paris, France

    Anne Bertrand

Authors
  1. Elisabeth Maillart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caroline Papeix
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charles Mellerio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anne Bertrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Catherine Lubetzki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Céline Louapre
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elisabeth Maillart.

Ethics declarations

Conflicts of interest

EM has received conference fees from Biogen, Genzyme, Novartis, and Teva. CP has received conference fees from Biogen, Genzyme, Novartis, Roche, and Teva. CM reports no disclosures. AB reports no disclosures. CLu has received conference fees from Roche, Biogen, Genzyme, and Novartis and participated to Vertex advisory board. CLo reports travel fees from Genzyme.

Ethical standard

The manuscript submitted for publication has been performed with ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maillart, E., Papeix, C., Mellerio, C. et al. Extensive and severe CNS demyelination associated with golimumab therapy. J Neurol 263, 1869–1871 (2016). https://doi.org/10.1007/s00415-016-8238-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-016-8238-5

Keywords

Search

Navigation